Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Piperidone | HCID 12665 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 59457464 | HCID 59457464 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 59457504 | HCID 59457504 | — |
Reaction Steps
A suspension of delta-valerolactam (0.14 g, 1.4 mmol, 1 eq) and sodium hydride (60% dispersion in mineral oil, 0.056 g, 1.4 mmol, 1 eq) in N,N-dimethylformamide (10 ml) is cooled to 0° C. and treated with 4-(chloromethyl)-2-[4-(3-chloropropoxy)phenyl]-1,3-oxazole ax57 (0.4 g, 1.4 mmol, 1 eq). The mixture is then stirred at room temperature. After 20 h, the solvent is evaporated, the residue is taken up in ethyl acetate and washed two times with an aqueous solution of sodium hydrogenocarbonate. The organic layer is dried over magnesium sulfate, filtered and concentrated under vacuum to give 0.58 g of 1-({2-[4-(3-chloropropoxy)phenyl]-1,3-oxazol-4-yl}methyl)piperidin-2-one i55 immediately engaged in the next step without any further purification.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07790720B2 |
|---|
| Source dataset | uspto-grants-2010_09 |
|---|
| ORD ID | ord-210db43e922f4ef9ac924f1f527c48a6 |
|---|
| Source note | uspto-grants-2010_09 |
|---|